A detailed history of Mc Clarren Financial Advisors, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Mc Clarren Financial Advisors, Inc. holds 1,152 shares of JNJ stock, worth $179,101. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,152
Previous 1,023 12.61%
Holding current value
$179,101
Previous $442,000 5.2%
% of portfolio
0.05%
Previous 0.31%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$145.48 - $167.38 $18,766 - $21,592
129 Added 12.61%
1,152 $419,000
Q2 2024

Jul 26, 2024

SELL
$144.38 - $157.78 $288,326 - $315,086
-1,997 Reduced 66.13%
1,023 $442,000
Q1 2024

Jul 26, 2024

BUY
$155.22 - $162.74 $296,780 - $311,158
1,912 Added 172.56%
3,020 $478,000
Q1 2024

May 03, 2024

SELL
$155.22 - $162.74 $295,538 - $309,856
-1,904 Reduced 63.21%
1,108 $478,000
Q4 2023

Feb 02, 2024

BUY
$145.6 - $158.88 $1,456 - $1,588
10 Added 0.33%
3,012 $472,000
Q2 2023

Aug 04, 2023

BUY
$154.35 - $166.11 $54,485 - $58,636
353 Added 13.33%
3,002 $496,000
Q1 2023

May 05, 2023

BUY
$151.05 - $180.26 $604 - $721
4 Added 0.15%
2,649 $408,000
Q4 2022

Jan 30, 2023

BUY
$160.2 - $179.79 $45,016 - $50,520
281 Added 11.89%
2,645 $467,000
Q3 2022

Oct 31, 2022

BUY
$161.33 - $179.52 $110,672 - $123,150
686 Added 40.88%
2,364 $386,000
Q2 2022

Aug 11, 2022

SELL
$168.19 - $186.01 $67,612 - $74,776
-402 Reduced 19.33%
1,678 $297,000
Q4 2021

Jan 19, 2022

BUY
$155.93 - $173.01 $29,782 - $33,044
191 Added 10.11%
2,080 $356,000
Q3 2021

Oct 15, 2021

BUY
$161.5 - $179.47 $16,311 - $18,126
101 Added 5.65%
1,889 $305,000
Q2 2021

Jul 23, 2021

SELL
$159.48 - $171.07 $2,392 - $2,566
-15 Reduced 0.83%
1,788 $294,000
Q1 2021

Apr 21, 2021

BUY
$153.07 - $170.48 $153 - $170
1 Added 0.06%
1,803 $296,000
Q4 2020

Jan 29, 2021

BUY
$137.11 - $157.38 $247,072 - $283,598
1,802 New
1,802 $283,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Mc Clarren Financial Advisors, Inc. Portfolio

Follow Mc Clarren Financial Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Clarren Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mc Clarren Financial Advisors, Inc. with notifications on news.